Sales and Marketing

Showing 15 posts of 11527 posts found.

Cialis OTC approval sought

June 2, 2014 Sales and Marketing Cialis, ED, OTC, Sanofi, lilly

Sanofi and Eli Lilly have announced they are to push ahead with plans to seek regulatory approval for erectile dysfunction …

Lemtrada resubmitted to FDA

June 2, 2014 Sales and Marketing FDA, Lemtrada, MS, Sanofi

Sanofi has resubmitted its application for Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis (MS) to the …

Masters Speciality Pharma hires two

June 2, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters, mosa, rosetti

UK-based pharma supply firm Masters Speciality Pharma has made two new key appointments to strengthen its team. Ivan Rosetti (pictured) …

David Haslam: NICE, drug pricing and ethics

June 2, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chairman, Dillon, NHS, NICE, adams, has lam

Since 2010, I have spent a great deal of time of writing about NICE, covering nearly all of all its …

ASCO 2014: old dogs, new tricks top the bill

June 2, 2014 Research and Development, Sales and Marketing ASCO, Cancer, chicago, docetaxel, exemestane

 Research showing the effectiveness of established cancer treatments in new settings is taking centre stage at this year’s American Society …

Italy eyes €1.2 billion pharma fine

May 30, 2014 Sales and Marketing Novartis, Roche, avastin, off label, wet and

Italy’s health ministry says it is looking for €1.2 billion in damages from Roche and Novartis over claims that the …

Pharma still lagging behind docs and patients in digital

May 30, 2014 Medical Communications, Sales and Marketing digital, eye for pharma, marketing, multichannel

The pharma industry is still struggling with multichannel marketing which is putting it out of sync with patients and doctors, …

GSK pondering £7.5 billion drugs sale

May 30, 2014 Sales and Marketing GSK, Paxil, ageing, drugs, established, imitrex, zofran

GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …

IT director Chris Roche joins Aridhia

May 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMC, IT, Roche, aridhia

Health tech informatics firm Aridhia has appointed Chris Roche to a newly-created post on its executive team as chief commercial …

BMJ slams EMA ‘U-turn’

May 30, 2014 Medical Communications, Research and Development, Sales and Marketing BMJ, EMA, alltrials, data, transparency

The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …

£47.5 million fund for UK life sciences

May 29, 2014 Research and Development, Sales and Marketing European Investment Fund, Scottish Enterprise, Strathclyde Pension Fund, UK, epidarex, life sciences, lilly

A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …

Samsung health platform launched

May 29, 2014 Medical Communications, Sales and Marketing Apple, Samsung, heathtech, iwatch, smart band, wearable

Samsung has taken another step towards realising the potential of wearable health tech with the launch of a new ‘smart’ …

Boehringer settles US lawsuits

May 29, 2014 Medical Communications, Sales and Marketing Boehringer, Pradaxa, US, blood, lawsuits, warfarin

Boehringer Ingelheim has sought to bring to an end around 4,000 legal cases which have been brought against the company …

Taiho hires head from BMS

May 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, taiho, whiten

Japan-based pharma firm Taiho Oncology has appointed Tim Whitten to the position of senior vice president and chief commercial officer. …

GSK now faces UK investigation

May 28, 2014 Medical Communications, Research and Development, Sales and Marketing China, GSK, Poland, UK, bribery, corruption, iraq, sfo

The woes of GlaxoSmithKline look set to continue as the UK’s Serious Fraud Office (SFO) has launched a criminal probe …
The Gateway to Local Adoption Series

Latest content